Yongxian Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yongxian Jiang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
A. Huang
Cancer Centre, Wuhan Union Hospital, Whuan, China
1 shared publication- Bo Wu
Department of Neurosurgery, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
1 shared publication D. Han
Cancer Centre, Wuhan Union Hospital, Whuan, China
1 shared publication- Dan Zhang
Xi'an Fanyi University, Shaanxi, China, 710105
1 shared publication - Gen Li
University of Electronic Science and Technology of China, China
1 shared publication - Guiying Li
Department of Nephrology, Affiliated Hospital of Hebei University of Engineering, Handan, Hebei, People’s Republic of China
1 shared publication
Latest Publications
- 1 September 2021
- Published by Elsevier in Annals of Oncology
- Vol. 32, S753-S754
777P A prospective, single-arm, open-label study of camrelizumab, apatinib and nab-paclitaxel in patients with advanced cervical cancer
- 1 September 2021
- Published by Elsevier in Annals of Oncology
- Vol. 32, S753-S754
777P A prospective, single-arm, open-label study of camrelizumab, apatinib and nab-paclitaxel in patients with advanced cervical cancer
- Open Access
- 1 July 2020
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (7) , 890-893
Strategic plan for the management of COVID-19 in an obstetrics department
Pregnant women are vulnerable during infectious disease outbreaks due to their special physiological state3 . Because of physiological changes in the immune and cardiopulmonary systems, pregnant women are more likely to develop severe illness after respiratory infection4 . According to previous research, SARS-CoV and MERS-CoV (highly homologous to SARS-CoV-2) are both known to be responsible for severe complications during pregnancy, including the need for endotracheal intubation, admission to an intensive care unit (ICU), renal failure, and death5 . Up to now, no study showed that pregnant women are more likely to be infected with COVID-19, and pregnancy outcomes are worse in diagnosed patients, and interrelated research is very inadequate6 .Other than the maternal adverse effects of COVID-19, its potential impact on fetal and neonatal outcomes has not been ruled out either. Therefore, standard procedures are urgently needed to avoid hospital-related infection and guide the management of pregnant patients. Here, we proposed a strategic plan for the management of COVID-19 outbreaks in Obstetrics Departments, primarily focusing on the prevention and control strategies of viral infection.
- 1 July 2020
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 66 (7) , 890-893
Open AccessStrategic plan for the management of COVID-19 in an obstetrics department
Pregnant women are vulnerable during infectious disease outbreaks due to their special physiological state3 . Because of physiological changes in the immune and cardiopulmonary systems, pregnant women are more likely to develop severe illness after respiratory infection4 . According to previous research, SARS-CoV and MERS-CoV (highly homologous to SARS-CoV-2) are both known to be responsible for severe complications during pregnancy, including the need for endotracheal intubation, admission to an intensive care unit (ICU), renal failure, and death5 . Up to now, no study showed that pregnant women are more likely to be infected with COVID-19, and pregnancy outcomes are worse in diagnosed patients, and interrelated research is very inadequate6 .Other than the maternal adverse effects of COVID-19, its potential impact on fetal and neonatal outcomes has not been ruled out either. Therefore, standard procedures are urgently needed to avoid hospital-related infection and guide the management of pregnant patients. Here, we proposed a strategic plan for the management of COVID-19 outbreaks in Obstetrics Departments, primarily focusing on the prevention and control strategies of viral infection.